Correlation Between HCW Biologics and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Scpharmaceuticals, you can compare the effects of market volatilities on HCW Biologics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Scpharmaceuticals.
Diversification Opportunities for HCW Biologics and Scpharmaceuticals
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Scpharmaceuticals is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of HCW Biologics i.e., HCW Biologics and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between HCW Biologics and Scpharmaceuticals
Given the investment horizon of 90 days HCW Biologics is expected to generate 15.56 times more return on investment than Scpharmaceuticals. However, HCW Biologics is 15.56 times more volatile than Scpharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 50.00 in HCW Biologics on August 25, 2024 and sell it today you would earn a total of 27.00 from holding HCW Biologics or generate 54.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Scpharmaceuticals
Performance |
| Timeline |
| HCW Biologics |
| Scpharmaceuticals |
HCW Biologics and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Scpharmaceuticals
The main advantage of trading using opposite HCW Biologics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |